Clovis Oncology
Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the USA, Europe and additional international markets.
The USA-based company targets development programs at specific subsets of cancer populations, and simultaneously develops diagnostic tools that direct a compound in development to the population that is most likely to benefit from its use.
Latest Clovis Oncology News & Features
10 November 2022
Today's issue
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze